Navigation Links
Echo Therapeutics To Present at Prestigious 'Innovations in Diabetes' Conference
Date:7/9/2009

ny tCGM System. These and other risks and uncertainties are identified and described in more detail in Echo's filings with the Securities and Exchange Commission, including, without limitation, its annual report on Form 10-K for the year ended December 31, 2008, its quarterly reports on Form 10-Q, and its current reports on Form 8-K. Echo Therapeutics, Inc. undertakes no obligation to publicly update or revise any forward-looking statements.

    10 Forge Parkway
    Franklin, MA 02038, USA
    Tel: 1+ 877-476-6878
    Fax: 1+ 508-553-8760
    www.echotx.com


    For More Information:
    Patrick T. Mooney, MD
    Chairman and Chief Executive Officer
    (508)-530-0329


'/>"/>
SOURCE Echo Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Fate Therapeutics to Present Data on Stimulation of Osteogenic Activity Using Small Molecule Modulators of Wnt Pathway
2. New Report Just Published: World Multiple Myeloma Therapeutics Market Report
3. New Report Just Published: World Hepatitis C Virus And Therapeutics Market Report
4. Catalyst Biosciences Announces Agreement With MedImmune to Discover and Develop Engineered Protease Therapeutics
5. European Medicines Agency (EMEA) Approves Cell Therapeutics, Inc.s September Meeting Request to Discuss OPAXIO(TM) Marketing Authorization Application
6. Fate Therapeutics Granted Exclusive License By The Regents of the University of California to Stem Cell Modulators for Osteo-Regeneration
7. Hyperion Therapeutics Raises $60 Million Series C
8. Cornerstone Therapeutics Joins the Russell 3000(R) Index
9. Global Autoimmune Disease Therapeutics Market to Reach $50 Billion by 2015, According to a New Report by Global Industry Analysts
10. Intrinsic Therapeutics Barricaid and Magellan Spine Technologies DART to Drive European Annulus Repair Market
11. Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...wswire/--Hazelden,theinternationallyrenownednonpro...rshipteamforitsnewrecoverycenterinNaples,Florida.H...lateMarch2010,andwillinitiallyprovideaddictiontrea...andoutpatientservices. ,, MichaelDemask,Ph.D.,w...aples,withBrendaIliff,M.A.,L.A.D.C.,asclinicaldire...
(Date:11/23/2009)...mSupportsFutureLeadersinSTEMFields ,, Scholar...n ceS c holars.org ,, WASHINGTON,No...ountusin.Withourcommunity,foundation,andcorporatep...ate,"saidAdolphP.Falcon,SeniorVicePresidentoftheNa...teHousemeetingtodaywherePresidentObamaannouncedthe...
(Date:11/23/2009)...re/--CortivaInstituteTucsonwillhostanIntroductiont...theschool,s6390EastBroadwayBlvd.location,whichwill...icebasicmassagestrokes. ,, "Massagetherapyisagr...longwithit,"saidJoannMcMaster,presidentofCortivaIn...or,s2009-2010OccupationalOutlookHandbookstatesthat...
(Date:11/23/2009)...Howistheeconomyaffectingpeople,swellness?According...ss&theEconomy,theeconomyismakinguscollectively...exerciseanddiettoonethatismoreinwardlyfocusedonada...tdramaticfindingwasthechangeinconsumers,definition...thandwellbeingtotoday,smorerelevantconcernsaboutad...
(Date:11/23/2009)...errors self-reported by American surgeons are stro... findings appear today in the online edition of A...ded collaborators from Johns Hopkins and the Ameri...l study, nearly 9 percent of U.S. surgeons respond...hs prior to being surveyed. Over 70 percent attrib...
Breaking Medicine News(10 mins):Health News:Hazelden Names Leadership Team for New Recovery Center in Naples, Florida 2Health News:Alliance Joins President Obama at White House in Commitment to Science, Technology, Engineering, and Math (STEM) Education 2Health News:Cortiva Institute To Host Workshop, Hands-On Opportunity for Prospective Students 2Health News:Being Well Is About Reinvention - Not Health 2Health News:Being Well Is About Reinvention - Not Health 3Health News:Burnout and mental distress strongly related to errors by US surgeons 2
... Although the median price ...ively stable since January, 2009 (1 April, 09 Bloo...ast year, and the NZ dollar decline of between 16 ...erty in the South Island. , ...
... Medtral New Zealand offers...ican patients seeking a viable, safe alternative t... Long Beach, CA (PRWEB) April 8, 2009 --...ry as he has no health insurance. At the same time...
...Multiple, anatomically distinct lung cancer tumors...ccording to a retrospective analysis of patient tu...of the Journal of the National Cancer Institute. ...n appearance, it has been unclear whether they ari...
...ouncil Will Hear Public Comments on Comparative Ef...t , , ROCKVILLE, Md., April 7 The Federal Coordi...rch will hold a public listening session on April ...es. , , "The Obama Administration is committed to...
...h-intensity early treatment may lead to more inter...Y, April 7 (HealthDay News) -- More intensive trea...early bladder cancer doesn,t appear to improve pat...he average cost of care for patients who received ...
...Modern moms and dads snap thousands of photos, rec...o crawl. Until now, this frenzy of activity could ...ing their child,s health and developmental progres...letters, and at the same time tracks a child,s dev...
Other Medicine News:Health News:New Zealand Beach Front Property Offers Global Currency Rate Bargains 2Health News:A New Zealand Experience That Improves Lives: Arizona Man Finds Affordable, Quality Healthcare and Freedom From Constant Hip Pain on Recent Trip 2Health News:A New Zealand Experience That Improves Lives: Arizona Man Finds Affordable, Quality Healthcare and Freedom From Constant Hip Pain on Recent Trip 3Health News:Multifocal lung cancers appear to originate from single cancer clone 2Health News:Federal Coordinating Council on Comparative Effectiveness Research to Hold Public Listening Session in Washington, DC 2Health News:Intensive Early Treatment Doesn't Help Bladder Cancer Survival 2Health News:Digital album puts focus on kids' health 2Health News:Digital album puts focus on kids' health 3
(Date:11/23/2009)...ewswire/--Sarnova,Inc.,thenation,sleadingspecialty...alservices(EMS)andrespiratorymarkets,announcedtoda...mentteam.ThenewexecutivesincludeTomDavid,executive...entandgeneralcounsel;SteveLacke,executivevicepresi...sidentofcorporatedevelopment. ,, "Ihaveworkedwi...
(Date:11/23/2009)...ire/--ProteonTherapeutics,Inc.,hasinitiatedaPhase1...-stagerenaldisease(ESRD)patientsundergoingsurgeryf...sentsProteon,ssecondhumanclinicalstudyinhemodialys...se1/2studyofPRT-201inESRDpatientsundergoingsurgery...r.ProteonalsoannouncestheappointmentofboardmemberG...
(Date:11/23/2009)...irstCall/--CordBloodAmerica,Inc.(OTCBulletinBoard:...pany( http://www.cordblood-america.com )focusedonb...alinsurancepolicy,tofamiliesnationwideandinternati...wwithCEOandco-founderMatthewSchisslerisnowavailabl...le/2875811 . ,, Intheinterview,Mr.Schisslerupda...
Breaking Medicine Technology:Sarnova Expands Senior Management Team 2Proteon Initiates Second Phase 1/2 Clinical Study of PRT-201 in Hemodialysis Patients 2Fewer Dying Now From Abdominal Aortic Aneurysms 50813 1Fewer Dying Now From Abdominal Aortic Aneurysms 50813 2NCI renews Mayo Clinic Cancer Center support grant extends comprehensive status 50811 1NCI renews Mayo Clinic Cancer Center support grant extends comprehensive status 50811 2Purdue researchers create prostate cancer homing device for drug delivery 50809 1Purdue researchers create prostate cancer homing device for drug delivery 50809 2Purdue researchers create prostate cancer homing device for drug delivery 50809 3Purdue researchers create prostate cancer homing device for drug delivery 50809 4
... N.J., May 18, 2007 /PRNewswire-FirstCall/ -- A to...l studies with,Schering-Plough,s hepatitis product... and REBETOL(R) (ribavirin, USP) combination,thera...as well as,boceprevir (SCH 503034), the company,s ...tly in Phase II clinical development, will,be pres...
...(BUSINESS WIRE)--May 21, 2007 - Roche today announ...l patients who,discontinued treatment with Peg-Int...o adverse events within the first 12 weeks, were,a...(R),(peginterferon alfa-2a) and ribavirin. Further... on and complete a full course of,treatment with P...
Other Medicine Technology:Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 2Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 3Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 4Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 5Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 6Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 7Data Suggest that Pegasys May be an Option in Hepatitis C Patients,Unable to Tolerate Peg-Intron 2Data Suggest that Pegasys May be an Option in Hepatitis C Patients,Unable to Tolerate Peg-Intron 3Data Suggest that Pegasys May be an Option in Hepatitis C Patients,Unable to Tolerate Peg-Intron 4Data Suggest that Pegasys May be an Option in Hepatitis C Patients,Unable to Tolerate Peg-Intron 5Data Suggest that Pegasys May be an Option in Hepatitis C Patients,Unable to Tolerate Peg-Intron 6
Lyphochek Coagulation Control
...ance Specimens are intended for use in assessing c...n guidelines, including chain of custody, for Fede...he Substance Abuse and Mental Health Services Admi...artment (HHS) and other federal agencies. These sa...
Lyphochek Hemoglobin A2 Control
Liquichek Reticulocyte Control
Medicine Products: